Dealing in securities by prescribed officers
Johannesburg, 24 March 2023. In compliance with paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following information is disclosed:
| Name of prescribed officer: | J van Heerden |
| Name of Company: | Harmony |
| Date of transaction | 23 March 2023 |
| Type of transaction: | On-market sale of ordinary shares |
| Class of securities: | Ordinary shares |
| Number of shares: | 12 290 |
| Volume Weighted Average price per share: | R74.29 |
| Highest sale price: | R74.38 |
| Lowest sale price: | R74.25 |
| Total value of shares: | R912 972.90 |
| Nature and extent of interest | Direct beneficial |
| Name of prescribed officer: | M van der Walt |
| Name of Company: | Harmony |
| Date of transaction | 24 March 2023 |
| Type of transaction: | On-market sale of ordinary shares |
| Class of securities: | Ordinary shares |
| Number of shares: | 56 279 |
| Volume Weighted Average price per share: | R72.0486 |
| Highest sale price: | R72.54 |
| Lowest sale price: | R71.80 |
| Total value of shares: | R4 054 821 |
| Nature and extent of interest | Direct beneficial |
Prior clearance was obtained in respect of the above dealings by the prescribed officers.
Ends.
For more details, contact:
Jared Coetzer
Head: Investor Relations
+27 (0) 82 746 4120
Johannesburg, South Africa
24 March 2023
Sponsor:
J.P. Morgan Equities South Africa Proprietary Limited